Business
0
'We will crack gene therapy': Elevidys fallout doesn't dent Roche's hopes for modality - Fierce Biotech
The uncertainty around the future of Elevidys hasn’t destroyed Roche’s belief in the potential of gene therapies, the Swiss company’s head of pharma has told Fierce Biotech, as the pharma continues | The uncertainty around the future of Elevidys hasn’t destro…
Comments